256 related articles for article (PubMed ID: 18267346)
1. Interleukin-10 is a protective factor against diet-induced insulin resistance in liver.
Cintra DE; Pauli JR; Araújo EP; Moraes JC; de Souza CT; Milanski M; Morari J; Gambero A; Saad MJ; Velloso LA
J Hepatol; 2008 Apr; 48(4):628-37. PubMed ID: 18267346
[TBL] [Abstract][Full Text] [Related]
2. The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice.
Pinto Lde F; Compri CM; Fornari JV; Bartchewsky W; Cintra DE; Trevisan M; Carvalho Pde O; Ribeiro ML; Velloso LA; Saad MJ; Pedrazzoli J; Gambero A
Liver Int; 2010 Apr; 30(4):603-10. PubMed ID: 20088867
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action.
Wunderlich FT; Ströhle P; Könner AC; Gruber S; Tovar S; Brönneke HS; Juntti-Berggren L; Li LS; van Rooijen N; Libert C; Berggren PO; Brüning JC
Cell Metab; 2010 Sep; 12(3):237-49. PubMed ID: 20816090
[TBL] [Abstract][Full Text] [Related]
4. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of diet-induced diabetes mellitus by removal of visceral fat.
Pitombo C; Araújo EP; De Souza CT; Pareja JC; Geloneze B; Velloso LA
J Endocrinol; 2006 Dec; 191(3):699-706. PubMed ID: 17170226
[TBL] [Abstract][Full Text] [Related]
6. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
Cong WN; Tao RY; Tian JY; Liu GT; Ye F
Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 to tumor necrosis factor-alpha ratio is a predictive biomarker in nonalcoholic fatty liver disease: interleukin-10 to tumor necrosis factor-alpha ratio in steatohepatitis.
Hashem RM; Mahmoud MF; El-Moselhy MA; Soliman HM
Eur J Gastroenterol Hepatol; 2008 Oct; 20(10):995-1001. PubMed ID: 18787467
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
Qin B; Anderson RA; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor protects the liver against alcohol-induced injury and sensitization to bacterial lipopolysaccharide.
Deaciuc IV; D'Souza NB; Burikhanov R; Lee EY; Tarba CN; McClain CJ; de Villiers WJ
Alcohol Clin Exp Res; 2002 Jun; 26(6):864-74. PubMed ID: 12068256
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease.
Kathirvel E; Morgan K; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):973-83. PubMed ID: 19307976
[TBL] [Abstract][Full Text] [Related]
11. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice.
Vitto MF; Luz G; Luciano TF; Marques SO; Souza DR; Pinho RA; Lira FS; Cintra DE; De Souza CT
Horm Metab Res; 2012 Nov; 44(12):885-90. PubMed ID: 22932913
[TBL] [Abstract][Full Text] [Related]
12. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver.
Hsieh PS; Jin JS; Chiang CF; Chan PC; Chen CH; Shih KC
Obesity (Silver Spring); 2009 Jun; 17(6):1150-7. PubMed ID: 19247274
[TBL] [Abstract][Full Text] [Related]
13. Chlorpromazine exacerbates hepatic insulin sensitivity via attenuating insulin and leptin signaling pathway, while exercise partially reverses the adverse effects.
Park S; Hong SM; Lee JE; Sung SR
Life Sci; 2007 Jun; 80(26):2428-35. PubMed ID: 17512020
[TBL] [Abstract][Full Text] [Related]
14. Glycine attenuates endotoxin-induced liver injury by downregulating TLR4 signaling in Kupffer cells.
Xu FL; You HB; Li XH; Chen XF; Liu ZJ; Gong JP
Am J Surg; 2008 Jul; 196(1):139-48. PubMed ID: 18565339
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
[TBL] [Abstract][Full Text] [Related]
16. Reconsideration of insulin signals induced by improved laboratory animal diets, Japanese and American diets, in IRS-2 deficient mice.
Hashimoto H; Arai T; Mori A; Kawai K; Hikishima K; Ohnishi Y; Eto T; Ito M; Hioki K; Suzuki R; Ohsugi M; Saito M; Ueyama Y; Okano H; Yamauchi T; Kubota N; Ueki K; Tobe K; Tamaoki N; Kadowaki T; Kosaka K
Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):577-86. PubMed ID: 19629935
[TBL] [Abstract][Full Text] [Related]
17. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
[TBL] [Abstract][Full Text] [Related]
18. Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity.
Samane S; Christon R; Dombrowski L; Turcotte S; Charrouf Z; Lavigne C; Levy E; Bachelard H; Amarouch H; Marette A; Haddad PS
Metabolism; 2009 Jul; 58(7):909-19. PubMed ID: 19394055
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
20. The role of cytokines in non-alcoholic fatty liver disease.
Tilg H
Dig Dis; 2010; 28(1):179-85. PubMed ID: 20460908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
